Leaflet ISOTREXIN gel 0.05% / 0.2%
Indicated for: acne vulgaris
Route of administration: cutaneous
Substance: isotretinoin + erythromycin (retinoid + macrolide antibiotic)
ATC: D10AD54 (Dermatologicals | Anti-acne preparations for topical use | Retinoids for topical use in acne)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Effective contraception is required during treatment.
Do not use this medicine during pregnancy.
Avoid excessive exposure to sunlight or UV radiation.
This medicine may affect fetal development.
The combination of isotretinoin and erythromycin is used to treat moderate to severe acne. Isotretinoin reduces sebum production and inflammation, while erythromycin is an antibiotic that targets bacteria associated with acne.
The medication is available as a gel or cream and is applied topically to affected areas, usually once or twice daily, as directed by a doctor.
Side effects may include local irritation, dryness, or redness of the skin. In rare cases, severe allergic reactions may occur.
Patients should avoid prolonged sun exposure and use sunscreen. Pregnant or breastfeeding women should consult a specialist before use.
General data about ISOTREXIN GEL 0.05% / 0.2%
- Substance: isotretinoin + erythromycin
- Date of latest medicines list: 01-06-2016
- Product code: W07819001
- Concentration: 0.05% / 0.2%
- Pharmaceutical form: gel
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for isotretinoin + erythromycin
- 0.05%/0.2%
- 0.5mg/20mg/g